pravastatin has been researched along with thyroxine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsiang, B; Kirchgessner, TG; Sasseville, V; Wang, Z; Wu, Y; Yang, WP; Zhu, Y | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abouelnaga, ZA; Alhaj, MA; Awad, MM; Citro, LA; El-Sayed, O; Elnakish, MT; Hassanain, HH; Hassona, MD; Khan, M; Kulkarni, A; Kuppusamy, P; Moldovan, L; Sayyid, M | 1 |
| Alhaj, MA; Elnakish, MT; Hassanain, HH; Hassona, MD; Janssen, PM; Khan, M; Moldovan, L | 1 |
| Elnakish, MT; Hassanain, HH; Janssen, PM; Khan, M; Moldovan, L | 1 |
| Cann, RC; Hurel, SJ; Laing, C; Marks, DJ | 1 |
1 review(s) available for pravastatin and thyroxine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for pravastatin and thyroxine
| Article | Year |
|---|---|
A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters.
Topics: Amino Acid Sequence; Animals; Anion Transport Proteins; Base Sequence; Biological Transport; Carrier Proteins; Dehydroepiandrosterone Sulfate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Molecular Sequence Data; Pravastatin; Rats; Taurocholic Acid | 1999 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Cardiac remodeling caused by transgenic overexpression of a corn Rac gene.
Topics: Aging; Amino Acid Sequence; Analysis of Variance; Animals; Echocardiography; Genotype; Hypertrophy, Left Ventricular; Integrin alpha1; Integrin beta1; Magnetic Resonance Imaging; Male; MAP Kinase Signaling System; Mice; Mice, Transgenic; Molecular Sequence Data; Mutation; Myocardium; Myosin Heavy Chains; Phenotype; Plant Proteins; Pravastatin; Promoter Regions, Genetic; rac1 GTP-Binding Protein; Superoxides; Thyroxine; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2011 |
Rac-induced left ventricular dilation in thyroxin-treated ZmRacD transgenic mice: role of cardiomyocyte apoptosis and myocardial fibrosis.
Topics: Animals; Apoptosis; Blotting, Western; Carbazoles; Cardiomegaly; Cardiomyopathies; Carvedilol; Echocardiography; Female; Fibrosis; Male; Mice; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Pravastatin; Propanolamines; rac GTP-Binding Proteins; Thyroxine; Vasodilator Agents | 2012 |
Myocardial Rac1 exhibits partial involvement in thyroxin-induced cardiomyocyte hypertrophy and its inhibition is not sufficient to improve cardiac dysfunction or contractile abnormalities in mouse papillary muscles.
Topics: Animals; Cardiomegaly; Echocardiography; Electrocardiography; Heart; Heart Ventricles; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Myocardial Contraction; Myocytes, Cardiac; Neuropeptides; Papillary Muscles; Pravastatin; rac GTP-Binding Proteins; rac1 GTP-Binding Protein; Thyroxine | 2013 |
Acute kidney injury after Chernobyl.
Topics: Acute Kidney Injury; Chernobyl Nuclear Accident; Hormone Replacement Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypothyroidism; Male; Middle Aged; Pravastatin; Radiation Injuries; Rhabdomyolysis; Risk Factors; Severity of Illness Index; Thyroid Function Tests; Thyroxine; Time Factors | 2015 |